Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1992 1
1993 1
1995 1
1997 1
1999 1
2000 1
2001 1
2002 4
2003 2
2004 1
2006 3
2007 2
2008 2
2009 1
2010 1
2011 2
2012 2
2013 2
2014 6
2015 4
2016 3
2017 2
2018 6
2019 7
2020 8
2021 6
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC.
Olsen EA, Whittaker S, Willemze R, Pinter-Brown L, Foss F, Geskin L, Schwartz L, Horwitz S, Guitart J, Zic J, Kim YH, Wood GS, Duvic M, Ai W, Girardi M, Gru A, Guenova E, Hodak E, Hoppe R, Kempf W, Kim E, Lechowicz MJ, Ortiz-Romero P, Papadavid E, Quaglino P, Pittelkow M, Prince HM, Sanches JA, Sugaya M, Vermeer M, Zain J, Knobler R, Stadler R, Bagot M, Scarisbrick J. Olsen EA, et al. Blood. 2022 Aug 4;140(5):419-437. doi: 10.1182/blood.2021012057. Blood. 2022. PMID: 34758074 Free PMC article.
In addition, staging of the PCLs has been evolving based on new data on potential prognostic factors, diagnosis, and assessment methods of both skin and extracutaneous disease and a desire to align the latter with the Lugano guidelines for all NHLs. ...
In addition, staging of the PCLs has been evolving based on new data on potential prognostic factors, diagnosis, and assessment metho …
Aggressive cutaneous T-cell lymphomas.
Junkins-Hopkins Md JM. Junkins-Hopkins Md JM. Semin Diagn Pathol. 2017 Jan;34(1):44-59. doi: 10.1053/j.semdp.2016.11.004. Epub 2016 Dec 24. Semin Diagn Pathol. 2017. PMID: 28187925 Review.
Cutaneous T cell lymphomas (CTCLs) are heterogeneous, with a prognosis determined in large part by combined clinical, histopathologic, and immunophenotypic features. ...Whether or not a patient diagnosed with CTCL will experience an aggressive course may not be comp …
Cutaneous T cell lymphomas (CTCLs) are heterogeneous, with a prognosis determined in large part by combined clinical, histopathologic …
Recent Advances in Cutaneous T-cell Lymphoma: Diagnostic and Prognostic Considerations.
Cocks M, Porcu P, Wick MR, Gru AA. Cocks M, et al. Surg Pathol Clin. 2019 Sep;12(3):783-803. doi: 10.1016/j.path.2019.03.006. Surg Pathol Clin. 2019. PMID: 31352988 Review.
Distinguishing histologic clues to diagnosis are discussed, and important molecular advances are described. Key prognostic indicators that may assist clinicians with timely and appropriate management options are presented....
Distinguishing histologic clues to diagnosis are discussed, and important molecular advances are described. Key prognostic indicators …
Primary Cutaneous B-Cell Lymphomas with Large Cell Morphology: A Practical Review.
Ronchi A, Vitiello P, D'Abbronzo G, Caccavale S, Argenziano G, Sica A, Alfano R, Savarese G, Berretta M, Cozzolino I, Franco R. Ronchi A, et al. Int J Mol Sci. 2023 Mar 25;24(7):6204. doi: 10.3390/ijms24076204. Int J Mol Sci. 2023. PMID: 37047176 Free PMC article. Review.
Nevertheless, differential diagnosis in the setting of this group of neoplasms is mandatory to identify the correct therapy and prognosis, but it may be challenging since, due to the rarity of these neoplasms, they may not always be familiar to pathologists. ...
Nevertheless, differential diagnosis in the setting of this group of neoplasms is mandatory to identify the correct therapy and prognosis …
Cutaneous Lymphomas -Part II: Other Cutaneous Lymphomas.
Pujol RM, Gallardo F. Pujol RM, et al. Actas Dermosifiliogr (Engl Ed). 2021 Jan;112(1):24-31. doi: 10.1016/j.ad.2020.09.005. Epub 2020 Oct 10. Actas Dermosifiliogr (Engl Ed). 2021. PMID: 33045210 Free article. English, Spanish.
They make up a heterogeneous group of tumors that have different clinical and pathological features. Clinical course also varies. Presenting as papules, nodules, or tumors of variable reddish-violaceous coloring, the lesions may be solitary or multiple and occasionally for …
They make up a heterogeneous group of tumors that have different clinical and pathological features. Clinical course also varies. Pre …
Pediatric Primary Cutaneous Lymphoma in China: A Retrospective Study.
Zhang C, Jiang Y, Xu X, Sun J, Chen H. Zhang C, et al. Dermatology. 2023;239(4):553-564. doi: 10.1159/000530884. Epub 2023 May 18. Dermatology. 2023. PMID: 37231916
Primary cutaneous anaplastic large cell lymphoma, subcutaneous panniculitis-like T-cell lymphoma, primary cutaneous peripheral T-cell lymphoma, rare subtypes and primary cutaneous B-cell lymphoma, respectively, accounted for 2.0%, 4.0%, 4.0%, and 3.0%. Most patients had favorable …
Primary cutaneous anaplastic large cell lymphoma, subcutaneous panniculitis-like T-cell lymphoma, primary cutaneous peripheral T-cell lympho …
The role of 18F-FDG PET and PET/CT in the evaluation of primary cutaneous lymphoma.
Qiu L, Tu G, Li J, Chen Y. Qiu L, et al. Nucl Med Commun. 2017 Feb;38(2):106-116. doi: 10.1097/MNM.0000000000000614. Nucl Med Commun. 2017. PMID: 27792043 Review.
Accurate classification and staging are important for making treatment recommendations for PCL and will further impact patient prognosis significantly. We review the role of fluorine-18-fluorodeoxyglucose (F-FDG) PET (F-FDG PET) and F-FDG PET with computed tomography (CT) …
Accurate classification and staging are important for making treatment recommendations for PCL and will further impact patient prognosis …
CD4 + primary cutaneous small/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature.
James E, Sokhn JG, Gibson JF, Carlson K, Subtil A, Girardi M, Wilson LD, Foss F. James E, et al. Leuk Lymphoma. 2015 Apr;56(4):951-7. doi: 10.3109/10428194.2014.938331. Leuk Lymphoma. 2015. PMID: 24996443 Review.
CD4 + primary cutaneous small/medium-sized pleomorphic T-cell lymphoma (CD4 + PCSM-TCL) is a rare T-cell lymphoma associated with a favorable prognosis. A retrospective study of 23 patients with CD4 + PCSM-TCL as defined by World Health Organization-European Organisation f …
CD4 + primary cutaneous small/medium-sized pleomorphic T-cell lymphoma (CD4 + PCSM-TCL) is a rare T-cell lymphoma associated with a favorabl …
Local radiation for cutaneous T-cell lymphoma other than mycosis fungoides and Sézary syndrome.
Shikama N. Shikama N. Chin Clin Oncol. 2019 Feb;8(1):8. doi: 10.21037/cco.2018.07.01. Epub 2018 Jul 19. Chin Clin Oncol. 2019. PMID: 30180750 Free article. Review.
The most common relapse site after local treatment is other skin areas; however, skin relapse is not associated with worsened prognosis. Subcutaneous panniculitis-like T-cell lymphoma (SPTL) without hemophagocytic syndrome exhibits indolent behavior, and localized lesions …
The most common relapse site after local treatment is other skin areas; however, skin relapse is not associated with worsened prognosis …
72 results